focus -WSS

focus

author：knowledge 2025-09-29 01:09:42 - browse：9357

TALLINN, Estonia -- A Belarusian journalist was sentenced Friday to four years in prison after being convicted of aiding extremist activities as the authoritarian country continues a severe crackdown on the opposition and independent reporting.

The trial of video journalist Pavel Padabed was held behind closed doors. His conviction and sentencing were reported by the Belarusian Association of Journalists.

Padabed worked with Belsat, a Polish-funded satellite channel that broadcasts into Belarus and is considered by the Belarusian government to be “extremist media.”

The journalists' association said material presented at his trial included investigative programs about the disappearance of a videographer and the 2016 car bombing in Ukraine of TV journalist Pavel Sharemet.

Belarus President Alexander Lukashenko, in power since 1994, has taken an increasingly repressive line toward the opposition and independent journalists since mass protests engulfed the country in 2020 following a presidential election that gave him a sixth term in office but was widely regarded as fraudulent.

The journalists' association says 34 journalists are currently behind bars.

More than 35,000 people were arrested during the 2020 protests, and many were severely beaten by police. The Belarusian human rights group Viasna says there are nearly 1,500 political prisoners in the country.

Exiled opposition leader Sviatlana Tsikhanouskaya, who ran against Lukashenko in 2020, met Friday with European Council President Charles Michel and EU foreign policy chief Josep Borrell.

Afterward, the European Council issued a statement calling on Belarus to stop allowing Russia to base troops there for use in the war in Ukraine and end the deployment there of Russian tactical nuclear weapons.

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Take antibiotics after sex, CDC recommends for certain risk groups

entertainment

WSS

Canadians with cystic fibrosis outlive Americans by a decade

STAT wants to know your pick for a great summer read or listen

Finland to offer bird flu vaccine to select groups of people, a possible global first

FDA approves Moderna’s RSV vaccine, its second licensed product

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

STAT wants to know your pick for a great summer read or listen

hotspot

focus

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

AstraZeneca lung cancer study comes in below expectations

Duchenne breakthrough therapy leaves behind pioneering families

A letter from the executive editor: The 2023 STATUS List

Medical leaders decry Supreme Court decision on affirmative action

ASCO Daily Recap: CAR

Hepatitis C has a cure — but many Americans still lack access to it

'Little Tech' descents on D.C., wanting a say in how AI is regulated

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Eli Lilly’s Zepbound improved liver scarring in mid

leisure time

'Screen and refer' systems are hurting patients

Illumina board agrees to spin off Grail, as divestment plans proceed

'Screen and refer' systems are hurting patients

Finland to offer bird flu vaccine to select groups of people, a possible global first

AstraZeneca lung cancer study comes in below expectations

How CO2 helps viruses stay alive longer in the air

hotspot

focus

entertainment

hotspot